Latest News From BioPharmaChem


  • Baxalta Inc signs deal to develop drugs for rare cancers

    05 January, 2016

    Drugmaker Baxalta Inc has signed a deal with privately held Symphogen under which the companies will develop immuno-oncology drugs to treat rare cancers.

    Continue Reading »

  • Irish Medtech Firm to raise €15 million to develop bone repair technology

    07 January, 2016

    SurgaColl Technologies, a fledgling Irish medtech company is looking to raise €15 million to develop and commercialise revolutionary technology that will allow doctors to repair bone and cartilage in patients.

    Continue Reading »

  • Dublin based Venn Life Sciences signs contracts worth over €3.4m

    12 January, 2016

    The AIM-listed Irish company provides clinical trial management to pharmaceutical, biotech and medical device companies.

    Continue Reading »

  • New Pharmaceutical centre of excellence established in Cork

    13 January, 2016

    Scientific consumer research firm, SRL Research, has teamed up with UCC’s School of Pharmacy and the Clinical Research Facility Cork (CRF-C) at Mercy University Hospital to establish a dedicated centre of excellence - SRL PHARMA

    Continue Reading »

  • Irish Medical Technology Company 3D4Medical announces 70 new jobs

    15 January, 2016

    The company will create positions in the highly skilled technical, design and medical sectors including: software developers, 3D graphic artists and medical writers and experts, to build on the success of its world-renowned applications.

    Continue Reading »

  • February

  • Galway based Creganna Medical Group sold for $895 million

    02 February, 2016

    Creganna Medical Group, which is owned by Permira Funds, makes medical equipment and devices that are used in minimally invasive procedures. Communication equipment maker TE Connectivity announced it is to purchase the Galway-based medical device maker for $895 million.

    Continue Reading »

  • AstraZeneca's new lung cancer drug wins early approval for use in the EU

    03 February, 2016

    The company said today that the European Commission granted conditional marketing authorisation for Tagrisso to treat patients with a certain type of lung cancer

    Continue Reading »

  • Dublin based Sigmoid Pharma to buy Irish arm of Japanese group Freund

    08 February, 2016

    Speciality drug business Sigmoid Pharma has agreed to buy the Irish business of Japanese pharmaceutical equipment group Freund. The transaction, the terms of which were not disclosed, will see it acquire a manufacturing plant in Tullamore along with research and development facilities and other assets.

    Continue Reading »

  • Galway based Pharma company to create 175 new jobs

    11 February, 2016

    Chanelle Group, the largest Irish-owned manufacturer of pharmaceuticals, will create 175 jobs in a major expansion of its operations. Chanelle, which already employs 375 people, is making a €70 million investment that will double its production capacity and add to its research and development capabilities, as it looks to break into the US market for generic drugs.

    Continue Reading »

  • MSD to create 200 jobs in Cork, Tipperary and Carlow

    15 February, 2016

    The company company will add the roles to its existing Irish workforce of more than 2,000 staff. MSD’s Carlow facility will receive the bulk of the new positions with 110 new jobs to be filled, while 50 will be created at its Cork base and a further 40 in Tipperary.

    Continue Reading »

  • Pharmaceutical research firm APC to create 100 jobs at new Dublin HQ

    16 February, 2016

    The 100 jobs will all be highly-skilled research and development jobs across the areas of chemical engineering, sciences and analytics.

    Continue Reading »

  • Stryker to buy Physio Control for $1.28bn

    17 February, 2016

    Stryker which employs almost 1,000 people in Ireland will acquire US-based Physio-Control which makes devices such as defibrillators for emergency treatment of cardiac arrests.

    Continue Reading »

  • GSK announces €12m investment project at its Cork based manufacturing site

    26 February, 2016

    GSK, who last year celebrated 40 years in Cork, employs 450 employees at the Cork site. The global healthcare company employs over 1,800 staff across four locations in Ireland. – Cork, Dublin, Waterford and Sligo.

    Continue Reading »

  • US MedTech firm Alere creates 40 new jobs in Galway

    29 February, 2016

    US medical diagnostics firm Alere is to create 40 new jobs at its Galway facility as part of an expansion plan for its Irish operation. The medtech firm plans to triple the number of its carried out at its operation in Ballybrit, resulting in over 150 million rapid diagnostic tests being carried out.

    Continue Reading »

  • March

  • Pharmaceutical Auditing Training Course

    03 March, 2016

    Avail of Pharmaceutical Auditing Training via PharmaChem Skillnet.... Across the many diverse business functions within the pharmaceutical industry, the requirement to perform audits of key service and material suppliers has become a significant driver for regulatory compliance and corporate governance. A successful audit relies on both the technical ability and the soft skills of the auditor(s)

    Continue Reading »

  • Spanish Pharma group Grifols announces additional $85m investment in Dublin plant

    08 March, 2016

    The investment is part of a larger programme which will see the group build four new plants in a $360 million expansion of its bioscience manufacturing capacity.

    Continue Reading »

  • Economy grows at fastest pace since 2000

    10 March, 2016

    The economy grew by 7.8 per cent last year, outstripping all other euro zone countries and most official forecasts. This is the fastest rate of growth recorded since 2000, when the economy expanded by 10.2 per cent. The latest quarterly national accounts, published by the Central Statistics Office, suggest economic activity is been driven by a strong recovery in domestic demand and a buoyant export trade

    Continue Reading »

  • Joint R & D project between US and Ireland announced by Science Foundation Ireland

    22 March, 2016

    At an event hosted in Washington DC yesterday, a tripartite US-Ireland R&D partnership was announced by Science Foundation Ireland. The “Centre-to-Centre” collaboration project is titled ‘Partnership in continuous manufacturing for nano-based drug products.’

    Continue Reading »

  • Provider required to deliver Franklin Covey 7 Habits of Highly Effective People Programmes

    31 March, 2016

    The PharmaChem Skillnet are currently seeking tender submissions from training providers to deliver the Franklin Covey 7 Habits of Highly Effective People Training Programmes. We are hoping to schedule programmes of various duration including the Foundation Programme.

    Continue Reading »

  • April

  • Eli Lilly to invest €35m in Kinsale facility

    06 April, 2016

    US pharmaceutical company Eli Lilly is to invest €35m in a new hi-tech manufacturing facility at its Kinsale campus in County Cork. The facility is expected to be fully operational by early 2017 and has the potential to “transform how medicines are made in the future”, according to the Indiana headquartered firm.

    Continue Reading »

  • Shire to create 400 jobs in Meath in the next 4 years

    16 April, 2016

    The company said it plans to create a “new, state of the art” biologics manufacturing campus on a 120 acre site at Piercetown, Co Meath. Construction of the new site will begin in the middle of this year with the site expected to be operational by mid-2019.

    Continue Reading »

  • June

  • Drug-maker Merck shares rise following cancer treatment sales

    29 June, 2016

    Merck Sharp & Dohme one of the true giants of the pharmaceutical industry in Ireland has seen an increase in revenue after the development of the cancer drug Keytruda. Keytruda can be used in the treatment of melonoma and lung cancers.

    Continue Reading »

  • July

  • Top 10 Pharma and Med Device Companies in Ireland

    14 July, 2016

    Ireland has attracted 9 of the world’s top 10 pharmaceutical companies and 18 of the top 25 medtech companies. The article in the link below discusses the top ten of these companies.

    Continue Reading »

  • August

  • Pharma group Jazz opens Athlone manufacturing plant

    02 August, 2016

    Jazz pharmaceuticals, an international biopharmaceutical company, is beginning work on a second facility in Ireland.

    Continue Reading »

  • Test

    08 August, 2016


    Continue Reading »

  • Limerick tech firm secures $6m funding from investors

    08 August, 2016

    A medical device company which has facilities in Limerick has just received $6m from investors. Teckro, the Limerick based company, intend to use this capital to modernize the clinical trial process.

    Continue Reading »

  • Alexion announces new €100m facility in Athlone

    09 August, 2016

    Project will deliver 50 jobs with workforce projected to reach 500 by 2019

    Continue Reading »

  • Future Skills Needs of the Biopharma Industry in Ireland

    11 August, 2016

    An investigation has been carried out by the department of jobs, enterprise and innovation into the future skills needs of the Irish workforce. The findings of this report are presented in the link below. Within this report, a program that the pharmachemskillnet has run is featured on page 40. This course generated fantastic results.

    Continue Reading »

  • New diabetes and cancer drugs deliver for Eli Lilly

    15 August, 2016

    It is fantastic to see a company based in Ireland doing so well. Eli Lilly, who are located in Dublin and Cork have recorded profits that surpassed estimates. This was due to their new diabetes and cancer drugs. These drugs include: Trulicity, Cyramza and Humalog. Eli Lilly have doubled their Irish workforce in the past five years. It is a good time to be working within the pharmaceuticals sector in Ireland.

    Continue Reading »

  • Ireland wants EU drug agency to move to Dublin after Brexit

    17 August, 2016

    In the aftermath of Britain's exit from the European union, Ireland is set to become the seat of the European Medicines Agency (EMA). This would put us at the forefront of the Pharmaceutical industry in Europe.

    Continue Reading »

  • Sterilization Depyrogenation Program

    18 August, 2016

    The Pharmachemskillnet is looking to source a provider to deliver a Sterilization Depyrogenation program in Q4 2016. If your company is in a position to quote for this please contact Susan at no later than Wednesday the 23rd of August 2016

    Continue Reading »

  • Forensic Auditing - Data Integrity Program

    18 August, 2016

    The Pharmachemskillnet is looking to source a provider to deliver a Forensic Auditing - data integrity program in Q4 2016. If your company is in a position to quote for this please contact Susan at no later than Friday the 26th of August 2016.

    Continue Reading »

  • Innovation awards: Sothic Bioscience could save horseshoe crab from extinction

    22 August, 2016

    A cork based pharmaceutical start up company has developed a synthetic equivalent to limulus amebocyte lysate (LAL). This is a compound found in horeshoe crab blood. LAL is used to detect the presence of pyrogens and bacterial contamination in injectable or implantable medical devices. This innovation will not only bring jobs to Cork in the manufacture and quality control of the synthetic equivalent of LAL, it will also help conserve horseshoe crab numbers in the Atlantic sea.

    Continue Reading »

  • Ireland has the perfect DNA to lead the global biopharma revolution

    24 August, 2016

    Ireland has all of the ingredients to make it one of the forerunners of the biopharmaceutical industry. These ingredients include an educated workforce, substantial government endorsement and the establishment of world class training institutions such as the National Institute for Bioprocessing Research and Training (NIBRT). This makes it a fantastic time to be beginning a career within the sector.

    Continue Reading »

  • Waterford looks forward to 200 new jobs at Pharmaceutical firm

    26 August, 2016

    The high potency drug producer EirGen Pharma is to employ 200 new workers in their Waterford based company. Founded in 2005 this company has gone from strength to strength. Last year EirGen was acquired by pharmaceutical giant, Opko. This will open up many opportunities within the pharma sector in Waterford City.

    Continue Reading »

  • Up to 8,400 Job Openings to Arise in the Irish Biopharma Sector by 2020

    29 August, 2016

    The biopharmaceutical industry in Ireland is set to continue to grow well into the future. It is projected that there will be 8,400 new jobs within the sector between now and 2020.

    Continue Reading »

  • VistaMed to Create 200 New Jobs in Co Leitrim

    31 August, 2016

    More good news for the medical device industry in Ireland. VistaMed produces catheters at a plant in Carrick-On-Shannon in Co. Leitrim. This plant specializes in the assembly of catheters. It is one of two VistaMad plants in Ireland. The other plant, in Roosky, Co. Rosscommon, is dedicated to the extrusion of the catheters.

    Continue Reading »

  • September

  • The Role of a Scientist in Biotech Evolves with the Sector

    05 September, 2016

    The article is a nice snap shot of what it is like to work within the biopharmaceutical industry at the moment. Within the article Bernadette Gallagher, of Bristol-Myers Squibb, is interviewed about her career progression within the pharma sector. Bernadette really captures the dynamic nature of working within a pharmaceutical company.

    Continue Reading »

  • Irish Invention may Revolutionize Biopharma Production

    07 September, 2016

    Process analytical technology (PAT), Is one of the biggest developments in Manufacturing technology in recent decades. This technology can be used to measure attributes such as product yield, pH and temperature within a reaction vessel in real time. A collaboration between the Tyndall Institute in Cork and NIBRT institution in Dublin has produced the PATsule. It will revolutionize the way that PAT is used within industry. Innovations such as this, are the reason why large pharmaceutical companies such as Pfizer, MSD and GSK set up facilities in Ireland.

    Continue Reading »

  • Galway Med Tech Firm Vivasure Raises €16.5m in Funding

    09 September, 2016

    A Galway-based medical device company has raised a considerable amount of capital to commercialize its newest innovative product. Vivasure which was founded in 2009 has produced an absorbate that can close up large-hole percutaneous vessels within a patient. This allows surgeons to finish heart surgery without needing to use stitches. This is a fantastic innovation which is more cost effective, less invasive and will most importantly help so many patients.

    Continue Reading »

  • Offaly-Based Medtech Firm Steripack sees Profits Jump

    12 September, 2016

    Steripack a company whos headquarters is based in Clara, Co. Offaly has witnessed a massive rise in profit in the past year. The company was bought over by US company Bemis for €70 million. This more than doubled this years profits. The company produces sterile packaging for the healthcare and pharmaceuticals industries.

    Continue Reading »

  • 110 jobs in Limerick as Biotech Firm Ortec Opens Euro HQ

    14 September, 2016

    US-based company, Ortec Inc is planning to set up its western European HQ in Newcastle West, Limerick. This company was established in 1980 in North Carolina. The site in Limerick is the first site commissioned outside of the United States. The company produce primarily polymers for a variety of different applications. Examples of these applications are as follows: pharmaceuticals, medical devices, excipients, bioabsorbable products, hygienic products, cosmetics and nutritional additives.

    Continue Reading »

  • Teva Pharmaceutical Industries Seeks Further Growth

    16 September, 2016

    Teva Pharmaceuticals which has sites based in Waterford and Dundalk has recently acquired Allergan pharmaceuticals. This deal which cost Teva a massive 40 billion dollars will allow the company to become the largest producer of generic drugs. They have plans to grow and produce between 1,000 and 1,500 new drugs a year. This will be good for the Waterford plant which deals with Research and Development of new products.

    Continue Reading »

  • NIBRT Partners with GE to Produce 1,500 ‘Bio-Professionals’ Annually

    19 September, 2016

    GE Healthcare has announced that they will invest €150 million into its Cork site over the next few years. They plan to collaborate with the NIBRT institute in Dublin to train staff members to produce 1,500 bio-professionals annually. The continual investment of global companies such as GE Healthcare into Irish sites will ensure that the biopharma industry within Ireland will continue to prosper into the future.

    Continue Reading »

  • Pharma Company Mallinckrodt to Create 75 New Jobs in Dublin

    21 September, 2016

    Mallinckrodt a company which is based in Blanchardstown, Dublin, has announced that it will create 40 new jobs in its R&D plant. The company who produces specialized X-Ray contrast media and generic analgesic drugs. This brings the number of individuals working within this plant to 120 overall.

    Continue Reading »

  • Life Science Career Opportunities - Biopharma, Medtech, Engineering Fair

    23 September, 2016

    A fantastic Event is happening in Athlone Institute of Technology on Wednesday the 28th of September. A careers fair which is focused at people searching for careers in the Biopharma, Medical Device and Engineering fields. There will be representatives from blue chip companies from all over Ireland as well as organisations helping job seekers such as the PharmaChemSkillnet. So if you are actively seeking a career in the sector it would be a great help in your efforts.

    Continue Reading »

  • Pharmaceutical Firm Plans 80 New Jobs

    26 September, 2016

    Alter Pharmaceuticals plans to create a further eighty jobs in their Dublin-based site. The company produces a range of generic drugs in areas such as oncology, cardiology and central nervous system disorders. The openings will be filled by 2018. These positions will be in a number of disciplines such as: research and development, regulatory, supply chain, warehouse, and quality.

    Continue Reading »

  • Life Sciences Opportunities Fair- Athlone Institute of Technology.

    29 September, 2016

    On Wednesday last there was a careers fair in Athlone Institute of Technology. The PharmaChemSkillnet had a stall open on the day speaking with JobSeekers about what we do. I hope if you came along to the stand that you got a better understand of the network and insight into what the Skillnet can do for you. The turn out to the event was fantastic with companies such as Johnson & Johnson, Alexion,Pfizer, Boston Scientific, Abbott among others attending the event. It was a great chance to network with industry.

    Continue Reading »

  • Galway Centre Gives Ireland Cutting Galway Edge in Medtech

    30 September, 2016

    €68 million has been invested in a new research center at NUI Galway. The facility will focus on tackling chronic diseases. The research center will keep Ireland on the innovative cutting edge of the medical device sector.

    Continue Reading »

  • October

  • Becton, Dickinson and Company Creates 20 Jobs In Drogheda

    03 October, 2016

    Medical device company; Becton, Dickinson and Company plans to create 20 jobs in Co. Lought. The company which is based in Drogheda produces PosiFlush syringes, used for insulin injection for use by diabetic patients. The site has received €38 million in investment to install to new production lines. The manufacture of one of these lines has already begun.

    Continue Reading »

  • Amryt Progresses Drug Development for Rare Disease

    05 October, 2016

    Dublin-based start up will progress its clinical trials to phase three in the near future. This is the final phase before a product is sent out for a trial basis on the market. The product known as Episalvan is an orphan drug designed to treat patients with Epidermolysis Bullosa. An orphan drug is a drug produced to treat rare chronic (meaning the disease is long-lasting) diseases. These diseases affect such a small percentage of the global population that it would not make economic sense to produce them. There are intensives set out by the European medical Agency (EMA) which make it more manageable for companies to produce these drugs. These incentives ensure that drugs that treat these rare illnesses are developed and manufactured. Amryt, Genzyme and Alexion are all producers of Orphan Drugs.

    Continue Reading »

  • GE to Ship in Pre-Made Pharma Factories to Cork in €150m Project

    10 October, 2016

    More Good news from GE Healthcare, Ringaskiddy, Cork. They have revealed that they intend to construct a GE BioPark in Ringaskiddy. The park will produce ready-made factories and sell them to companies who will soon begin commercial production of new pharmaceuticals. This will in turn speed up the process of getting these new pharmaceuticals to patients in need of them. GE Healthcare will begin recruiting 100 new employees in manufacturing, engineering and quality at the beginning of 2017

    Continue Reading »

  • Medtech Researcher Reveals How Passion Drives Her Success

    12 October, 2016

    In the article below a researcher in the medtech sector discusses what drives her through her PhD research. She is completing her PhD in the Tyndall institute, Cork, under the guidance of Dr. Eric Moore. The great thing about this article is that it shows the work that goes on in the background behind the innovations that make Ireland a key player in the medtech industry. Institutions such as the Tyndall, NIBRT and newly opened Cúram help to drive the growth pharma and medtech sectors in Ireland.

    Continue Reading »

  • Booming Biopharma goes from Strength to Strength

    14 October, 2016

    If you are on the fence about making a move into the pharmaceutical sector in Ireland this article will more than likely persuade you that this sector is the one to be in. With $ 8 million being invested in the biopharma industry in the last decade and 28,200 people employed within the sector this is one of the most affluent sectors within the Irish economy.

    Continue Reading »

  • Amgen Top Dog as Pharma Industry Award Winners Named

    17 October, 2016

    Last week Amgen scooped up two of the most coveted awards in the Pharma Industry Awards. These awards were: Pharma company of the year and bipharma company of the year. This is no small accomplishment considering that the company was up against pharma giants such as: Pfizer and Bristol, Myers, Squibb. Amgen produce pharmaceuticals for patients that do not have many options left with their treatment. They find ways to treat diseases through a biology first approach. This involves the use of advanced biological diagnostics to shed light onto the root causes of these illnesses.

    Continue Reading »

  • Aerogen Plans Global Move into Emergency Departments

    21 October, 2016

    Aerogen a Galway-based company has developed a new and innovative way to treat bronchospasm (a sudden narrowing of the airway). The innovation is to use a vibrating mesh to turn liquid medication into a fine mist. This will be an improvement over the conventional way of delivering respiratory medication which is by using a nebulizer. The new technology will ensure that more of the drug gets to the lungs where it is needed. The company employs around 70 people in Galway. This is a fantastic innovation made possible by the Irish Medical Devices industry. This industry should be bustling over the next decade with the establishment of the Cúram institute in Galway, which opened last month. This institute will bring more and more medical device innovations to Irish soil.

    Continue Reading »

  • Irish Firm Develops New Accessory for Insulin Pens

    24 October, 2016

    Yet another breakthrough for the Irish medical devices industry. Innovation Zed a company which has a research and development in NovaUCD, a research centre for new ventures and entrepreneurs. The research centre is affiliated with University College Dublin. A new product has been produced by Innovation Zed, called Insulcheck. This is a clip-on device which allows a patient with diabetes to monitor their insulin checks on the go. This will have great implications for patient care because healthcare professionals will be able to check how the patient has been taking their medication. This is one of the biggest problems with diabetes care at the moment. Doctors do not know how often patients administer their medication. This small clip-on device will give GPs and Healthcare professionals a way to monitor administration behaviours of the patients giving them the ability to cater the treatment strategy to patients behaviour.

    Continue Reading »

  • Bristol-Myers Squibb Careers Day Hosted in NIBRT

    26 October, 2016

    Bristol-Myers Squibb is holding a Careers day on the 12th of November in NIBRT. This is a fantastic opportunity for job seekers to network with industry. It is a must for anyone who is looking to get a foothold in the pharmaceutical industry.

    Continue Reading »

  • BMS: ‘We want people who have a can-do, will-do attitude’

    27 October, 2016

    Bristol-Myers Squibb (BMS) will be on a recruitment drive between now and the end of next year. The company invested $1 bn in the installation of a new manufacturing facility in Cruiserath, Dublin. This is the companies largest investment to date. The main opportunities will be in the following roles:manufacturing, engineering, quality, analytical science, automation and supply chain. By the end of 2017, 230 new employees will be recruited by the company. The roles will be a mix of senior and graduate roles. If you want to find out more about BMS and to network with employees within the company why not attend their careers event in NIBRT on the 12th of November (See the previous post).

    Continue Reading »

  • November

  • Genomics Medicine Ireland Raises €40m, to Create 150 Jobs

    01 November, 2016

    A clinical trial has been proposed to take place in Ireland. The trial will be conducted through a subsidiary of Amgen called deCode based in Iceland. The clinical trial will study the relationship between genetics and disease. The study will focus on diseases such as Alzheimer’s and multiple sclerosis to find potential treatments for these diseases. This will be a significant contribution to the field of genetic therapy.

    Continue Reading »

  • Pharma Firm PPD Set to Add 50 New Jobs in Athlone

    02 November, 2016

    A pharmaceutical company based in Athlone, Co. Westmeath is set to deliver 50 new jobs. Pharmaceutical Product Development (PPD) has expanded its facility in Athlone and when the expansion is finished, 200 individuals will be employed by the company in Ireland. This facility was opened in 2010 and this expansion shows the companies interest in operating in Ireland. PPD is a contract laboratory that aids in the development of pharmaceutical products. They can help with drugs in pre-clinical, clinical trials as well as help with products that have made it onto the market. The company has the capability to meet very complex development projects and specialises in bioanalytical, biomarkers, central lab, GMP and vaccine sciences.

    Continue Reading »

  • Irish Start-up Nuritas Leads Fight to Prevent Diabetes

    04 November, 2016

    Diabetes has been named by the World Health Organisation as an epidemic with 422 million people having the disease in the world. An Irish start up organization has gained funding to produce a supplement to prevent pre-diabetes. Pre-diabetes is a condition where the glucose levels inn a persons body are much higher than normal. Patients with Pre-diabetes run a high chance of developing type-2 diabetes. Nuritas has discovered a peptide that could potentially prevent people who have pre-diabetes from going on to develop full-blown diabetes. The start-up received funding from the 2020 Horizon incentive. This will help to combat this epidemic and hopefully lower the number of people get type 2 diabetes.

    Continue Reading »

  • Alzheimer’s Breakthrough Possible as ‘Switch-Off’ Drug Identified

    07 November, 2016

    A new Alzheimer's drug being developed by Merck could potentially be used to slow down the progression of the disease. It will also prevent the build up of plaque in the brain of the individual. The plaque that builds up in the brain is thought to build up on healthy neurons and to stop them from working. The new drug will prevent this plaque from being produced and will. In the clinical trial 32 patients with early stage, Alzheimer's disease were treated with the drug as well as healthy volunteers. It is sill early days however if the drug is fit for the market then it will be the first Alzheimer's drug produced in a decade. This is fantastic news for patients living with this condition

    Continue Reading »

  • Kinesis Health Technologies, the Creator of Devices that Prevent Falls in Older People, has Raised €590,000 to Expand Global Sales.

    09 November, 2016

    Kinesis Health Technologies, the manufacturer of technology that is capable of alerting attendants if an elderly patient has fallen. As people age they are more and more likely to have a fall due to the deterioration of balance, mobility and muscle strength. These falls could cause an elderly patient to be hospitalised for a long period of time and could cause them to lose their independence. The company manufacture a device that can be used to estimate how likely a patient is of falling and hurting themselves. This can be done easily by carrying out tests and they can also have wireless sensors which can be attached to protect patients that are at risk of falling. This company has received private investment to extend its manufacturing capabilities and to expand the range of products that they produce.

    Continue Reading »

  • Abbott Develops Star Trek-Like Device to Lessen Pain of Diabetes Readings

    11 November, 2016

    Med Tech Giant Abbott has developed a new device that can measure the glucose content of blood without having to prick your finger for blood. The Freestyle Libre sensor can be attached to the lower back or the arm to give a real-time measure of the glucose content in a patient's blood. The sensor does not require the patient to extract blood to work take the measurement. The device can keep track of the glucose levels over a period of 90 days which will allow them to see how they are doing overall. It is a fantastic innovation for diabetes care and the device is available commercially in Ireland now.

    Continue Reading »

  • Chanelle’s Global Innovation Award

    13 November, 2016

    Chanelle, a generic animal drug manufacturer, won the pharma industry award for Pharma Project of the Year 2016. The drug, Rheumocam, can be used to treat rheumatoid conditions in horses. Before the development of this generic drug, the API was produced as an injectable solution. This made it difficult to administer because the horse had to be handled by the owner. Rheumocam on the other hand was developed as a powder.The powder can be spread on the horses food. They even made the drug to taste like apples making it more delectable to the horse. What a great innovation.

    Continue Reading »

  • Skillnets Statement of Strategy launched

    Skillnets Statement of Strategy launched

    15 November, 2016

    Skillnets launched their Statement of Strategy 2016-2019 on November 3rd, 2016. Skillnets Statement of Strategy and ensuring goals are closely aligned with national policy and will contribute to the implementation of national workforce development aims as highlighted in Ireland's National Skills Strategy 2025.

    Continue Reading »

  • Genzyme Ireland Profits Rise to €68.5m

    18 November, 2016

    Genzyme is a company that produce orphan drugs. Orphan drugs are those which are used to treat chronic diseases. Chronic diseases affect a patient on a daily basis. Orphan drugs are produced for conditions that only affect a very small number of people in the population. In Genzyme, Waterford drugs are produced to treat inherited disorders, kidney disease and immune diseases. The company has made a profits rise last year to € 68.5m. 

    Continue Reading »

  • Amryt Pharma gets US Patent for Headline Drug

    21 November, 2016

    Amryt Pharma has been given a U.S. patent to start phase III studies of their drug in the U.S. The drug, Episalvan, is being developed to help with an orphan disease (see the previous post to learn more about orphan drugs and diseases) called epidermolysis bullosa (EB) and partial-thickness wounds. The company specialises in the development of novel treatments for patients suffering from orphan diseases. They have two other products currently in their pipeline. One of these drugs is to help patients with Cushing's disease. Prospects are looking up for this company as they move into 2017.

    Continue Reading »

  • A Very Healthy Sector as Growth Acts as Magnet for More Investment

    23 November, 2016

    The Medtech industry is booming in Ireland. This is because of well-executed planning from IDA Ireland. The production of a Medtech hub in Galway has attracted the giants of this industry to Ireland. At the moment 13 of the top 15 Medtech companies are based in Ireland. The foundation of Cúram as an institute attached to NUIG Galway further strengthens this hub and will make it more attractive towards medical Device manufacturers.

    Continue Reading »

  • Irish Researcher Awarded €8.8m to Develop Inhaler for Lung Disease

    24 November, 2016

    A researcher from Trinity college has gained a large investment to produce an inhaler for use in the treatment of Cystic Fibrosis. Cystic Fibrosis is where mucus builds up in the lungs of the individual, obstructing the breathing airways. Patients also have a higher chance of getting chest infections which can lead to other serious repercussions. The drug is being developed to break up the mucus which builds up in the lungs. This will free up the airway and will allow the patient to breathe again. The great thing about using an inhaler to deliver the drug is that the drug will be administered directly to the part of the body where it is needed, the lungs. This will ensure that more of the drug will make it to the lungs to break up the mucus.

    Continue Reading »

  • Enda Kenny Launches "Game Changing" €86m Bernal Institute at UL

    28 November, 2016

    The Bernal Research institution has opened up in conjunction with Limerick University. The institute will conduct research in the Engineering and Science fields. It was established through a collaboration between industry, higher education and industry. The state-of-the-art facility will hold 260 researchers who will focus on the following research areas: Advances in pharmaceuticals, medicines and materials science.

    Continue Reading »

  • December

  • Case Study: How Clinical Trial Helped One Cancer Patient

    01 December, 2016

    Participants in clinical trials may feel as though they are being used as guinea pigs. In some cases such as the one discussed in the article below, there is a lot that a patient can gain from a clinical trial. A man called Frank O' Duffy from Nenagh, Co. Tipperary took part in a phase III clinical trial. This is where the drug is administered to a patient who is suffering from the condition that the drug is trying to treat. At this stage, Frank's cancer had moved from a melanoma on his shin to his liver and his lungs. After taking part in a clinical trial his liver is now almost cancer-free. These trials allow patients to access new experimental drugs which may save their lives.

    Continue Reading »

  • West Pharmaceuticals to Create 100 New Jobs in Dublin Expansion

    02 December, 2016

    West pharma plans to expand its Dublin-based facility over the next 5 years. This will open 100 positions in the company. West pharma is a contract manufacturer of pharmaceutical components. They produce injection needles, caps and glassware for the containment and administration of pharmaceutical products. This is followed by the construction of a West pharma facility in Waterford city.

    Continue Reading »

  • Japanese Pharma Group to Invest €40m in New Dublin Facility

    05 December, 2016

    Takeda Pharmaceuticals plans to open a new facility in Dublin. The company will invest €40m to build this factory. Takeda has established three other facilities in Ireland. The other facilities are based in Grange Castle, City West and Bray. The site in Grange Castle is the world centre for the manufacture and development of Active pharmaceutical ingredients for Takeda. The companies investment into this new facility shows the Japanese companies continued interest in Ireland as an integral part of their global network.

    Continue Reading »

  • Osteoporosis Test Developed at UL to Benefit Millions of People

    08 December, 2016

    Ostentia, a technology which was in development in University Limerick between 2004 and now, will allow patients to diagnose whether they have osteoporosis from home. Before this technology was developed patients would need to undergo a bone mineral density test (BMD). The BMD test is similar to an X-Ray so this would require the patient to attend the hospital to be tested. The newly developed Ostentia however, can analyse a nail cutting and determine whether the patient has osteoporosis. The nail clipping is then put into a package and sent to the laboratory for testing. This is great for patients, they do not need to go to a hospital and a diagnosis can be given within 7 days. It is a fantastic innovation developed in Ireland.

    Continue Reading »

  • There's Much More to Ireland than Tax Breaks - Pharma Boss Grainne McAleese

    13 December, 2016

    Alexion, a company that produces drug products such as Soliris which help to treat ultra-rare diseases. These diseases can be life threatening for the patients that live with them because there is not extensive research done on these diseases. They are termed as orphan drugs and there are government intensives in place to give these companies the capital to conduct the research and to manufacture these drugs.This helps the patients to get a better quality of life and allows them to live longer. The article is an interview with Grainne McAleese, the general manager of the Alexion, Blanchardstown. Ms McAleese outlined Ireland's attractiveness to global pharmaceutical companies. We have the training, the infrastructure and the research centres which make us such an attractive location to establish a site. Ireland is a boiling pot with all of the right ingredients to allow the pharmaceutical industry to flourish, here.

    Continue Reading »

  • Amgen’s Adrian Bennis: Ireland at the cutting edge of fighting cancer

    15 December, 2016

    Traditional cancer drugs normally kill all kinds of cells. They do not distinguish between healthy and cancerous cells. This is quite a problem when fighting cancer with these more traditional drugs such as cisplatin or interferon. Side effects such as hair loss and nausea are caused by the cancer medication killing these quickly dividing cells. If more selective treatments are developed then cancer patients will not have to go through this ordeal. Amgen in Dún Laoghaire is developing a new cancer-fighting technology. This new technology is called BiTE ( see the video for more information). BiTE technology allows the body's immune system to better target cancer cells. It uses an antibody to bridge between t-cells, the cells that break down cancer cells, and the cancer cells so that your immune system can better fight off cancer. This will provide a better treatment for patients which has less severe side effects.

    Continue Reading »

  • Boom Time for Pharma Industry

    20 December, 2016

    The pharmaceutical sector in Ireland is still booming. The boom has been caused by a number of factors including clever government investment, industry/academic collaboration and an educated workforce. All of these factors make Ireland an attractive place for foreign investment. If anybody is in any way wondering whether the pharmaceutical sector is for them you should have a look at this article. It should convince you that it is a sector of growth with a good potential for career progression.

    Continue Reading »